Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Study Finds Non-Genetic Cancer Mechanism

July 27, 2015 8:52 am | by University of Leeds | News | Comments

The findings also open the possibility of new therapies aimed at measuring and preventing dangerous imbalances in cells. Read more...

TOPICS:

Molecular Clues to Serious Illnesses to Be Explored

July 27, 2015 8:47 am | by University of Manchester | News | Comments

Scientists in MMPathIC will also work with Manchester colleagues in the Manchester Cancer Research Centre to share ongoing advances that will assist in cancer diagnosis and treatment. Read more...

TOPICS:

FDA Approves Novartis' Drug for Treating Common Skin Cancer

July 27, 2015 8:39 am | by The Associated Press | News | Comments

Odomzo was approved for patients whose cancer hasn't spread to other body parts, but recurred after surgery or radiation therapy or can't be cured by those treatments. Read more...

TOPICS:
Advertisement

Teva Buys Allergan Generic Drug Company for $40.5B

July 27, 2015 8:35 am | by Daniel Estrin, Associated Press | News | Comments

Teva's leadership has been saying for months that it believes some of the biggest generic drug companies should combine in order to save money and become more efficient. Read more...

TOPICS:

Avanir: New Findings from Dementia Phase 2 Study

July 24, 2015 12:38 pm | News | Comments

Avanir Pharmaceuticals, Inc. today announced new findings from the dementia/Alzheimer's disease cohort of the PRISM II study, a phase IV study evaluating the safety and effectiveness of NUEDEXTA in treating pseudobulbar affect (PBA) in patients with dementia/Alzheimer's disease, stroke and traumatic brain injury (TBI). Read more...

TOPICS:

Lifestyle Changes May Guard Aging Brain Against Memory Loss

July 24, 2015 12:33 pm | by Lauren Neergaard, AP Medical Writer - Associated Press | News | Comments

The latest Alzheimer's research has a clear theme: Change your lifestyle to protect your brain. It will take several years for scientists to prove whether some experimental drugs could at least delay Alzheimer's disease, and an aging population is at risk now. Read more...

TOPICS:

Amgen Submits Supplemental NDA For Carfilzomib In Relapsed Multiple Myeloma

July 24, 2015 12:13 pm | News | Comments

Amgen today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection to seek an expanded indication for the treatment of patients with a form of blood cancer, relapsed multiple myeloma, who have received at least one prior therapy. Read more...

TOPICS:

For Prostate Cancer Patients, Risk-Specific Therapies Now More the Norm

July 24, 2015 12:09 pm | by UCSF | News | Comments

After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco. Read more...

TOPICS:
Advertisement

Algorithm Helps Scientists Decipher How Drugs Work Inside the Body

July 24, 2015 12:05 pm | by Columbia University | News | Comments

Researchers at Columbia University Medical Center (CUMC) have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body. The study, published in the journal Cell, could help researchers create drugs that are more efficient and less prone to side effects, suggest ways to regulate a drug’s activity. Read more

TOPICS:

Drug Discovery Spotlight: Mixed Results for Lilly, Biogen Alzheimer’s Drugs; Europe Approves Amgen’s Repatha

July 24, 2015 11:13 am | by Stephanie Guzowski, Editor | News | Comments

This week’s Alzheimer’s Association International Conference (AAIC) in Washington, D.C. delivered highly anticipated data, but not all lived up to the expectation of researchers and investors. Read about this news and more.

TOPICS:

Scientists Discover Why Some Prostate Cancer Tumors are Radiotherapy-Resistant

July 24, 2015 9:25 am | by University of York | News | Comments

The York team have now shown that they are the switch which enables cells to react very rapidly to changes in their environment, such as that provided by cancer treatments. Read more...

TOPICS:

Tracking Breast Cancer Before it Grows

July 24, 2015 9:16 am | by University of Saskatchewan | News | Comments

A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes. Read more...

TOPICS:

Zebrafish Reveal Drugs That May Improve Bone Marrow Transplant

July 24, 2015 9:11 am | by Harvard Gazette | News | Comments

The findings could lead to human trials in patients with cancer and blood disorders within a year or two. Read more...

TOPICS:

India's 'Medicine Baba' Gets Drugs from Rich, Gives to Poor

July 24, 2015 9:02 am | by Rishabh R. Jain, Associated Press | News | Comments

Some 40 percent of India's 1.2 billion people have no access to modern medicines because they are too expensive or simply unavailable in government hospitals where supplies are often scarce. Read more...

TOPICS:

EU Drug Regulator Recommends 1st License for Malaria Shot

July 24, 2015 8:54 am | by Maria Cheng, AP Medical Writer | News | Comments

The European Medicines Agency is recommending the world's leading malaria vaccine be licensed even though it is only about 30 percent effective and that protection fades over time. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading